Market News

Sangamo Biosciences (SGMO) Shareholder Ecor1 Capital Cut Its Holding by $35.19 Million; Huber Capital Management Maintains Stake in Ensco Plc (ESV)

Joe Huber increased its stake in Ensco Plc (ESV) by 39.68% based on its latest 2017Q3 regulatory filing with the SEC. Huber Capital Management Llc bought 1.13 million shares as the company’s stock declined 27.69% while stock markets rallied. The hedge fund run by Joe Huber held 3.99 million shares of the oil & gas production company at the end of 2017Q3, valued at $23.83 million, up from 2.86M at the end of the previous reported quarter. Huber Capital Management Llc who had been investing in Ensco Plc for a number of months, seems to be bullish on the $2.17B market cap company. The stock decreased 0.20% or $0.01 during the last trading session, reaching $4.96. About 8.77 million shares traded. Ensco plc (NYSE:ESV) has declined 23.23% since February 16, 2017 and is downtrending. It has underperformed by 39.93% the S&P500.

Ecor1 Capital Llc decreased its stake in Sangamo Biosciences Inc (SGMO) by 91.34% based on its latest 2017Q3 regulatory filing with the SEC. Ecor1 Capital Llc sold 2.35M shares as the company’s stock rose 95.00% with the market. The institutional investor held 222,388 shares of the health care company at the end of 2017Q3, valued at $3.34 million, down from 2.57 million at the end of the previous reported quarter. Ecor1 Capital Llc who had been investing in Sangamo Biosciences Inc for a number of months, seems to be less bullish one the $1.97B market cap company. The stock increased 1.30% or $0.3 during the last trading session, reaching $23.3. About 1.84M shares traded or 19.49% up from the average. Sangamo Therapeutics, Inc. (NASDAQ:SGMO) has risen 29.78% since February 16, 2017 and is uptrending. It has outperformed by 13.08% the S&P500.

Among 10 analysts covering Sangamo Biosciences (NASDAQ:SGMO), 7 have Buy rating, 1 Sell and 2 Hold. Therefore 70% are positive. Sangamo Biosciences had 22 analyst reports since August 8, 2015 according to SRatingsIntel. The firm has “Buy” rating by Jefferies given on Wednesday, September 2. The stock of Sangamo Therapeutics, Inc. (NASDAQ:SGMO) earned “Hold” rating by Wedbush on Monday, August 14. Jefferies maintained Sangamo Therapeutics, Inc. (NASDAQ:SGMO) rating on Tuesday, September 12. Jefferies has “Buy” rating and $18.0 target. Piper Jaffray maintained the shares of SGMO in report on Wednesday, January 3 with “Buy” rating. The firm has “Outperform” rating given on Friday, December 4 by Wells Fargo. The stock has “Sell” rating by Zacks on Tuesday, September 8. Jefferies maintained Sangamo Therapeutics, Inc. (NASDAQ:SGMO) on Friday, October 13 with “Buy” rating. The stock of Sangamo Therapeutics, Inc. (NASDAQ:SGMO) has “Hold” rating given on Thursday, August 10 by Piper Jaffray. The rating was maintained by Cowen & Co with “Buy” on Friday, September 4. As per Wednesday, November 15, the company rating was upgraded by PiperJaffray.

Since September 1, 2017, it had 0 insider purchases, and 8 insider sales for $1.88 million activity. $308,855 worth of Sangamo Therapeutics, Inc. (NASDAQ:SGMO) was sold by Herberts Curt A. III. $237,159 worth of Sangamo Therapeutics, Inc. (NASDAQ:SGMO) shares were sold by Mento Steven J. 5,000 shares valued at $85,545 were sold by Conner Edward R. on Monday, January 8.

Analysts await Sangamo Therapeutics, Inc. (NASDAQ:SGMO) to report earnings on February, 27. They expect $-0.18 EPS, down 28.57% or $0.04 from last year’s $-0.14 per share. After $-0.15 actual EPS reported by Sangamo Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 20.00% negative EPS growth.

Ecor1 Capital Llc, which manages about $750.32M US Long portfolio, upped its stake in Ascendis Pharma A S by 625,000 shares to 2.11M shares, valued at $76.40 million in 2017Q3, according to the filing. It also increased its holding in Fibrogen Inc by 150,220 shares in the quarter, for a total of 1.74 million shares, and has risen its stake in Corvus Pharmaceuticals Inc.

Investors sentiment decreased to 1.57 in Q3 2017. Its down 0.02, from 1.59 in 2017Q2. It dropped, as 17 investors sold SGMO shares while 32 reduced holdings. 27 funds opened positions while 50 raised stakes. 51.93 million shares or 2.16% more from 50.83 million shares in 2017Q2 were reported. Northern Trust owns 1.07 million shares or 0% of their US portfolio. Dimensional Fund Advsrs Limited Partnership holds 0% or 233,752 shares. Jane Street Ltd Co owns 41,591 shares or 0% of their US portfolio. 26,695 are owned by Gotham Asset Mngmt Ltd. Tower Rech Limited Liability Company (Trc) invested 0% in Sangamo Therapeutics, Inc. (NASDAQ:SGMO). State Board Of Administration Of Florida Retirement System accumulated 61,070 shares or 0% of the stock. Millennium Mgmt Limited Liability Corp reported 942,097 shares. Swiss Savings Bank has 0% invested in Sangamo Therapeutics, Inc. (NASDAQ:SGMO). Ameritas Investment Prtnrs owns 5,756 shares. Vanguard Grp Inc reported 0% stake. 30,923 are held by Gilder Gagnon Howe Com Ltd Limited Liability Company. 39,850 were accumulated by Leisure Capital Mngmt. Keybank Association Oh holds 0% of its portfolio in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) for 41,527 shares. Granahan Invest Mngmt Inc Ma reported 465,090 shares. Point72 Asset Lp invested in 693,300 shares.

Investors sentiment decreased to 0.99 in Q3 2017. Its down 0.02, from 1.01 in 2017Q2. It fall, as 48 investors sold ESV shares while 86 reduced holdings. 48 funds opened positions while 84 raised stakes. 328.54 million shares or 9.34% more from 300.48 million shares in 2017Q2 were reported. Laurion Limited Partnership owns 413,700 shares or 0.01% of their US portfolio. Basswood Mngmt Ltd Limited Liability Company owns 7,986 shares. 120,891 were reported by Virginia Retirement Et Al. Lmr Prtn Llp holds 0.01% in Ensco plc (NYSE:ESV) or 18,216 shares. 596,097 were accumulated by Agf Investments. Alliancebernstein LP has 449,180 shares. Retirement Systems Of Alabama holds 392,083 shares. Commonwealth Equity Svcs holds 0% or 53,167 shares in its portfolio. New York State Common Retirement Fund holds 1.41M shares or 0.01% of its portfolio. Stifel Financial Corp invested 0% in Ensco plc (NYSE:ESV). Aperio Limited Liability Co accumulated 368,556 shares. P Schoenfeld Asset Mngmt Ltd Partnership holds 0.65% or 1.75 million shares. Vertex One Asset Mgmt Inc invested 0.17% of its portfolio in Ensco plc (NYSE:ESV). Grantham Mayo Van Otterloo And Com Ltd reported 0.01% in Ensco plc (NYSE:ESV). 135 are owned by Glenmede Tru Company Na.

Among 34 analysts covering Ensco Plc (NYSE:ESV), 11 have Buy rating, 5 Sell and 18 Hold. Therefore 32% are positive. Ensco Plc had 82 analyst reports since August 3, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Tuesday, September 19 by Piper Jaffray. On Thursday, March 23 the stock rating was maintained by Scotia Capital with “Buy”. The rating was maintained by Cowen & Co with “Hold” on Thursday, January 11. The firm earned “Neutral” rating on Wednesday, March 16 by Citigroup. The stock has “Underperform” rating by Bank of America on Monday, June 13. As per Friday, January 12, the company rating was maintained by Susquehanna. The stock of Ensco plc (NYSE:ESV) earned “Neutral” rating by Susquehanna on Tuesday, June 28. Clarkson Capital upgraded the stock to “Neutral” rating in Thursday, September 22 report. The stock of Ensco plc (NYSE:ESV) has “Sell” rating given on Thursday, July 14 by Seaport Global. The rating was upgraded by Clarksons Platou to “Neutral” on Thursday, September 22.

Huber Capital Management Llc, which manages about $3.94 billion and $1.82B US Long portfolio, decreased its stake in Hp Inc by 71,329 shares to 264,136 shares, valued at $5.27 million in 2017Q3, according to the filing. It also reduced its holding in Tyson Foods Inc (NYSE:TSN) by 55,500 shares in the quarter, leaving it with 241,280 shares, and cut its stake in Entergy Corp New (NYSE:ETR).

Leave a Reply

Your email address will not be published. Required fields are marked *